Methylene blue: An old-timer or a compound ready for revival?

Critical Care Medicine

Volumn 34, Issue 11, 2006, Pages 2862-2863

  Donati, Abele ^a   Preiser, Jean Charles ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cardiac arrest; Hypoperfusion; Inflammation; Methylene blue; Septic shock

Indexed keywords

DROTRECOGIN; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EMERGENCY TREATMENT; FIBRINOLYSIS; FINANCIAL MANAGEMENT; HEART ARREST; HUMAN; INFLAMMATION; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; SEPTIC SHOCK; SURVIVAL;

ANIMALS; ENZYME INHIBITORS; FLUID THERAPY; HEART ARREST; HUMANS; INFLAMMATION; METHYLENE BLUE; REPERFUSION INJURY; SHOCK, SEPTIC;

EID: 33750272678     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000242915.26441.12     Document Type: Editorial

References (15)

1. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Part 3. Overview of CPR. Circulation 2005; 112(Suppl IV):IV12-IV18
2. Krismer AC, Lindner KH, Wenzel V, et al: Inhibition of nitric oxide improves coronary perfusion pressure and return of spontaneous circulation in a porcine cardiopulmonary resuscitation model. Crit Care Med 2001; 29:482-486
3. Miclescu A, Basu S, Wiklund L: Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest. Crit Care Med 2006; 34;2806-2813
4. Schleien CL, Kuluz JW, Gelman B: Hemodynamic effects of nitric oxide synthase inhibition before and after cardiac arrest in infant piglets. Am J Physiol 1998; 274:H1378-H1385
5. Preiser JC, Zhang H, Vincent JL: Administration of methylene blue in septic shock: Is it beneficial? In: Yearbook of Intensive Care and Emergency Medicine. Vincent JL (Ed). Berlin, Springer, 1994, pp 90-100
6. Preiser JC, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23:259-264
7. Donati A, Conti G, Loggi S, et al: Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 2002; 30:2271-2277
8. Levin RL, Degrange MA, Bruno GF, et al: Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004; 77:496-499
9. Viaro F, Dalio MB, Evora PR: Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: Should methylene blue be the treatment of choice? Chest 2002; 122:1061-1066
10. Salaris SC, Babbs CF, Voorhees WD III: Methylene blue as an inhibitor of superoxide generation by xanthine oxidase: A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol 1991; 42:499-506
11. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Nat Acad Sci U S A 1990; 87:1620-1624
12. Li J, Li W, Altura BT, et al: Peroxynitrite-induced relaxation in isolated rat aortic rings and mechanisms of action. Toxicol Appl Pharmacol 2005; 209:269-276
13. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis: Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. N Engl J Med 2001; 344:699-709
14. Evgenov OV, Sveinbjornsson B, Bjertnaes LJ: Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep. Acta Anaesthesiol Scand 2001; 45:1246-1254
15. Kirov MY, Evgenov OV, Evgenov NV, et al: Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study. Crit Care Med 2001; 29:1860-1867